Dried ashwagandha root and root powder, representing the stress-adaptogen guide

Ashwagandha and the Brain: What the Evidence Shows (and the Liver-Safety Question)

By Peter Benson, Cognitive Enhancement Researcher  ·  Updated October 2026  ·  Citations re-verified

Short answer: Ashwagandha’s best evidence is for stress: several small trials found standardised root extract lowered perceived stress and cortisol over six to eight weeks. Effects on sleep are small, and on cognition preliminary. It’s usually well tolerated in short trials, but it’s a likely cause of rare liver injury.

⚕️ Educational information, not medical advice — full disclaimer. Don’t use ashwagandha if you have liver disease, are pregnant or breastfeeding, or have prostate cancer, and check with your doctor first if you take thyroid, diabetes, blood-pressure, sedative or immune-suppressing medicines. Stop and seek advice if you notice yellowing skin or eyes, dark urine or itching. This page contains an affiliate link, in the buying section.

Quick Summary
Best evidenceStress and anxiety: several small trials found lower perceived stress and cortisol after six to eight weeks (Chandrasekhar et al., 2012; NIH ODS).
SleepA small improvement across five trials, all from India; possibly larger in people with insomnia (Cheah et al., 2021).
CognitionPreliminary, and possibly a knock-on effect of less stress and better sleep.
SafetyUsually well tolerated in trials of up to about three months, but NIH LiverTox rates it a likely cause of rare liver injury.
Trial doseUsually 250–600mg a day of a standardised root extract. A reference, not a prescription.

Ashwagandha is one of the best-selling supplements of the last decade, marketed for stress, sleep, energy and much more. Unlike many trendy supplements, it has a reasonable body of evidence behind its main claim, stress. But the trials are small and short, much of the research is funded by extract makers, and there’s a genuine safety signal for the liver that marketing tends to skip.

This ashwagandha guide covers how it’s thought to work, the evidence for stress, anxiety, sleep and cognition, the liver question, other cautions and regulatory concerns, and what to look for in a product. It sits in the Nootropics & Supplements hub.

What is ashwagandha and how might it work?

Ashwagandha (Withania somnifera) is a shrub used in Ayurvedic medicine, often called an adaptogen: something thought to help the body cope with stress. Its main active compounds are withanolides, which is why extracts are standardised to a withanolide percentage. Most trials use root extracts; some products also use leaf, which is more concentrated in some withanolides and has been the subject of separate safety concerns.

One proposed explanation is that ashwagandha influences the hypothalamic-pituitary-adrenal (HPA) axis, which helps regulate the stress response. Some human trials have reported lower cortisol, but that doesn’t establish exactly how ashwagandha produces its effects. Other proposed mechanisms, such as effects on GABA-related signalling, rest mainly on preliminary research. For context on the stress system itself, see chronic stress and cortisol.

Does ashwagandha reduce stress and anxiety?

Probably, modestly. In a widely cited trial, 64 stressed adults took 300mg of a standardised root extract (KSM-66) twice a day or placebo for 60 days. The ashwagandha group had larger falls in stress and anxiety scores and in blood cortisol, with side effects similar to placebo (Chandrasekhar et al., 2012).

It isn’t a one-off: NIH’s Office of Dietary Supplements summarises several studies in which people taking ashwagandha for six to eight weeks reported less stress and anxiety and had lower stress-hormone levels, with some finding 500–600mg a day more effective than lower doses (NIH ODS). But it describes the evidence as limited and varied, and concludes only that ashwagandha “might help reduce stress and anxiety.” It isn’t a substitute for treatment of an anxiety disorder.

Does ashwagandha help with sleep?

A little. A meta-analysis of five placebo-controlled trials (about 400 people, all in India) found a small improvement in overall sleep, rated moderate certainty. Subgroup analyses suggested larger effects in people with insomnia, with eight weeks or more of use, and with some higher-dose regimens (600mg a day or more) (Cheah et al., 2021). Subgroup comparisons like these don’t establish that 600mg is an optimal or universally effective dose. One of those trials, in 60 adults with insomnia and anxiety, used 300mg twice a day for eight weeks (Langade et al., 2019). NIH ODS calls the overall sleep benefits small (NIH ODS). For the wider picture, see sleep and recovery.

Does ashwagandha improve cognition?

The evidence is preliminary. Some small trials in stressed adults report improvements on memory or attention tests, but it’s unclear how much is a direct effect and how much follows from being less stressed and sleeping better. On current evidence, ashwagandha is best thought of as a stress-and-sleep supplement that might indirectly help thinking, not a nootropic to take for focus. See what to expect from nootropics.

How strong is the ashwagandha evidence?

Reasonable for a supplement, but with familiar limits. Most trials are small, last six to twelve weeks, are run in India, and many are funded by companies that make branded extracts. That doesn’t make the results worthless, but effect sizes may be flattering, and long-term effects are largely unstudied. NIH ODS notes that no safety concerns appeared in studies lasting up to about three months, but that it isn’t clear whether longer use is safe.

Newer systematic reviews pool more trials and generally report favourable results for perceived stress and anxiety-related symptoms. A 2026 dose-response meta-analysis in Complementary Therapies in Medicine included 22 randomised trials and 1,391 adults (Complementary Therapies in Medicine, 2026). But differences in extracts, doses, participants and study quality limit how confidently pooled results apply to everyday users. The newer evidence strengthens the case for a possible benefit; it doesn’t establish an optimal dose, long-term safety, or effectiveness as a treatment for anxiety or depression.

Is ashwagandha safe for your liver?

For most people in short trials, no liver problems have been reported. But in real-world use, ashwagandha has been linked to rare cases of liver injury. A case series from Iceland and the US Drug-Induced Liver Injury Network described five patients who developed jaundice after taking ashwagandha products (Björnsson et al., 2020). NIH LiverTox now rates ashwagandha a “likely cause” of clinically apparent liver injury (NIH LiverTox).

According to LiverTox, the injury usually appears 2 to 12 weeks after starting, typically with jaundice and itching. Most cases are mild to moderate and resolve within one to four months of stopping, but fatal liver failure has been reported, mainly in people with existing liver disease or cirrhosis. LiverTox advises against taking it again after a reaction. The reactions appear rare and unpredictable; whether product quality plays a part in some cases isn’t known.

Practically: avoid ashwagandha if you have liver disease, buy a tested product, don’t combine it carelessly with heavy alcohol or other substances known to stress the liver, and stop and seek medical advice promptly if you notice yellowing of the skin or eyes, dark urine, itching, unusual tiredness, nausea or upper-right abdominal pain. See are nootropics safe?.

Who else should be cautious?

Thyroid. Ashwagandha may affect thyroid function and could interact with thyroid medicines (NIH ODS). Use it only with medical advice if you have a thyroid condition.

Pregnancy, breastfeeding and prostate cancer. NIH ODS says it may not be safe in these groups.

Medicines. It may interact with diabetes and blood-pressure medicines, sedatives, and drugs that suppress the immune system (NIH ODS). Common side effects are usually mild: upset stomach, loose stools, nausea and drowsiness. If you have an autoimmune condition or surgery planned, ask your doctor first.

Regulators. Denmark banned ashwagandha in food supplements in 2023, after a Danish government-commissioned report found insufficient evidence to set a safe intake level. The Netherlands’ public-health institute advised against its use in 2024, and the UK Food Standards Agency has called for evidence on whether restrictions are needed (NutraIngredients, 2026). Industry groups dispute these assessments, and there’s no EU-wide ban, but they’re a sign that regulators consider the safety evidence incomplete.

Ashwagandha claims ranked by evidence

🟢 Stronger or replicated evidence  ·  🟡 Limited, mixed or preliminary evidence  ·  🔴 Not established or not supported

ClaimEvidenceBasis
Reduces perceived stress and cortisol🟡 PromisingSmall, short RCTs; certainty limited (Chandrasekhar 2012; 2026 meta-analysis; NIH ODS).
Reduces anxiety🟡 ModestSome RCTs; not a substitute for treatment.
Improves sleep🟡 Small effectFive RCTs, moderate certainty (Cheah 2021).
Directly sharpens cognition🟡 PreliminarySmall trials; may be indirect via stress and sleep.
Safe for long-term use🔴 Not establishedSafety data mostly up to ~3 months (NIH ODS).
Risk-free for the liver🔴 Not accurateLiverTox: likely cause of rare liver injury.

What dose did the trials use?

Most stress and sleep trials used a standardised root extract at 250–600mg a day, often 300mg twice a day, for six to twelve weeks. No optimal dose has been established. Many used the branded root extract KSM-66, standardised to about 5% withanolides, but extracts differ, so a dose of one isn’t equivalent to another. These are research references, not recommendations; effects, if any, build over weeks rather than hours.

Worked example — three people considering ashwagandha

A healthy adult in a stressful stretch at work. This resembles some participants in the stress trials, but the trials don’t establish that a supplement is appropriate for everyone under stress. Before considering a product, they should review the risks and medicine interactions, and the established approaches to stress such as sleep, workload and exercise. An eight-week period is a research reference, not a validated personal testing schedule.

Someone with an underactive thyroid on levothyroxine. Ashwagandha may affect thyroid function, so this is a conversation with their doctor before anything else.

Someone with fatty liver disease or who drinks heavily. Given the rare liver injury, which has been most serious in people with existing liver disease, this person is better off avoiding it.

The NeuroEdge Formula Ashwagandha Self-Testing Framework

If you decide to try it, in this order. Not a prescription.

1. Check safety first

Liver disease, pregnancy, thyroid conditions, prostate cancer, or thyroid, diabetes, blood-pressure, sedative or immune medicines: ask your doctor before starting.

2. Match the goal

Its evidence is for stress and, more weakly, sleep. Don’t expect a focus boost.

3. Understand what was studied

Trials used standardised root extracts at 250–600mg a day for six to twelve weeks. Those are research references; choose a tested product.

4. Review whether it’s appropriate

Trials assessed outcomes over several weeks, but that isn’t a validated personal testing period. An unblinded trial can’t reliably prove benefit or rule out delayed side effects. Stop and get prompt medical advice if symptoms suggest liver injury.

Peter’s Testing Notes

A personal note, not tracked data

I have tried ashwagandha and don’t take it now. For a long time I’d have described it simply as safe; reading the liver case reports changed that, and it’s why the safety sections here are as long as they are.

An earlier version of these notes described how it felt to take, in more detail than I can stand behind, so that has been removed.

Buying ashwagandha: what to check

Look for a root extract with the withanolide percentage and amount per serving stated, independent testing, and no leaf if you want to match most trials. Avoid unstandardised powders of unknown strength.

Root-only extracts are more directly comparable with many published trials, but that doesn’t mean they’re free of liver-injury risk. Independent testing can help confirm identity, composition and the absence of contaminants; it can’t guarantee that you won’t react to the herb itself.

Nootropics Depot Ashwagandha — KSM-66 root extract

KSM-66 standardised root extract, the type used in many of the stress trials. The company says its products are tested for purity and potency. I don’t take it now, and no trial has tested this specific product. The liver and thyroid cautions above apply to every brand.

This is an affiliate link. If you buy through it, NeuroEdge Formula may earn a commission at no extra cost to you. For a different adaptogen with a different evidence base, see Rhodiola.

Key takeaways

→Stress is ashwagandha’s best evidence, from several small, short trials showing lower perceived stress and cortisol.
→Sleep effects are small, and cognitive effects preliminary, possibly a knock-on from less stress.
→The research has limits: small, short trials, mostly in India, many funded by extract makers.
→It’s a likely cause of rare liver injury (NIH LiverTox). Avoid it with liver disease, and stop at signs such as jaundice or dark urine.
→Other cautions: thyroid, pregnancy, breastfeeding, prostate cancer, and several medicines. Long-term safety is unclear, and some regulators have restricted it.

Frequently asked questions

What is ashwagandha good for?

Its best evidence is for reducing perceived stress and anxiety, from several small trials of six to eight weeks. It may slightly improve sleep. Effects on cognition are preliminary.

Is ashwagandha safe for your liver?

For most people, liver problems haven’t appeared in short trials, but NIH LiverTox rates ashwagandha a likely cause of rare liver injury, usually 2 to 12 weeks after starting. Most cases resolve after stopping, but serious cases have occurred, mainly in people with existing liver disease. Avoid it if you have liver disease.

How long does ashwagandha take to work?

Trials measured effects after six to twelve weeks of daily use. It isn’t an acute calming agent, so a fair review point is about eight weeks, while watching for side effects.

What dose and form did trials use?

Usually a standardised root extract at 250–600mg a day, such as KSM-66 at 300mg twice a day. Extracts differ, so doses aren’t interchangeable. These are research references, not recommendations.

Who should avoid ashwagandha?

People with liver disease, and those who are pregnant, breastfeeding or have prostate cancer. People with thyroid conditions, or who take thyroid, diabetes, blood-pressure, sedative or immune-suppressing medicines, should check with their doctor first.

🧠

Get “7 Days to a Sharper Brain” — Free

Peter Benson’s evidence-first starting framework

The habits with the strongest evidence first — sleep, movement, stress and learning — then how to add a single supplement and test whether it actually works for you.

No spam. Unsubscribe anytime.

⚕️ Educational Information, Not Medical Advice

This article is educational and is not medical advice. I’m a cognitive enhancement researcher, not a medical doctor. Ashwagandha has been linked to rare liver injury and may affect thyroid function and interact with several medicines. Consult a qualified healthcare provider before use, particularly if you have liver or thyroid disease, take prescription medicines, or are pregnant or breastfeeding.

Scientific references

1. Chandrasekhar, K., Kapoor, J., & Anishetty, S. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 34(3), 255–262. DOI: 10.4103/0253-7176.106022

2. Langade, D., Kanchi, S., Salve, J., Debnath, K., & Ambegaokar, D. (2019). Efficacy and safety of ashwagandha (Withania somnifera) root extract in insomnia and anxiety: a double-blind, randomized, placebo-controlled study. Cureus, 11(9), e5797. DOI: 10.7759/cureus.5797

3. Cheah, K. L., Norhayati, M. N., Yaacob, L. H., & Abdul Rahman, R. (2021). Effect of Ashwagandha (Withania somnifera) extract on sleep: a systematic review and meta-analysis. PLoS One, 16(9), e0257843. PMID: 34559859

4. Björnsson, H. K., Björnsson, E. S., Avula, B., et al. (2020). Ashwagandha-induced liver injury: a case series from Iceland and the US Drug-Induced Liver Injury Network. Liver International, 40(4), 825–829. DOI: 10.1111/liv.14393

5. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Ashwagandha (updated December 2024). National Institute of Diabetes and Digestive and Kidney Diseases. ncbi.nlm.nih.gov

6. NIH Office of Dietary Supplements. Ashwagandha: is it helpful for stress, anxiety, or sleep? Fact sheet for consumers. ods.od.nih.gov

7. Effects of ashwagandha (Withania somnifera) on mental health in adults: a systematic review and dose-response meta-analysis of randomized controlled trials. (2026). Complementary Therapies in Medicine. PMID: 41644067

8. NutraIngredients. (2026, 6 July). Timeline: will authorities de-throne the king of herbs? (regulatory actions on ashwagandha). nutraingredients.com

Peter Benson

Cognitive Enhancement Researcher | 18+ Years Independent Research

Peter is not a clinician; this guide is educational, not medical advice. It was rewritten in October 2026 to add the sleep meta-analysis, the NIH LiverTox assessment, current NIH safety guidance and recent regulatory actions, to temper claims about the strength of the stress evidence, and to remove personal details that could not be confirmed. Read about how NeuroEdge Formula evaluates research.

Last reviewed: October 2026  |  Educational content only. Not medical advice.

Similar Posts